The genetics of type 2 diabetes

Endocrinologist

Volumn 11, Issue 3, 2001, Pages 178-187

  Lindgren, Cecilia M ^c   Hirschhorn, Joel N ^a,b,d,e  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CALPAIN; CALPAIN 10 PROTEASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE DERIVATIVE; PROTEINASE; UNCLASSIFIED DRUG;

CHROMOSOME; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC PREDISPOSITION; HEREDITY; HUMAN; MOLECULAR CLONING; MULTIFACTORIAL INHERITANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

EID: 0034977786     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200105000-00004     Document Type: Review

References (99)

1. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey, 1988;-1994
2. Diabetes trends in the U.S.: 1990;-1998
3. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2
4. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
5. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
6. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes
7. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
8. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
9. Prevention of long-term complications of non-insulin-dependent diabetes mellitus
10. Pharmacologic therapy for type 2 diabetes mellitus
11. Mapping genes in diabetes: Genetic epidemiological perspective
12. Risk factors for non-insulin-dependent diabetes
13. Risk of diabetes in offspring of parents with non-insulin-dependent diabetes
14. Prevalence and incidence of linkage studies in NIDDM-affected sib pairs
15. Concordance for type 2 (noninsulin-dependent) diabetes mellitus in male twins
16. Individual estimates of European genetic admixture associated with lower body-mass index, plasma glucose, and prevalence of type 2 diabetes in Pima Indians
17. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY
18. Genes: Here today gone tomorrow: A clinician's guide to genetic linkage and association studies
19. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
20. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (1DDM)
21. A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test
22. The future of genetic studies of complex human diseases
23. Genetic dissection of complex traits
24. Searching for genetic determinants in the new millennium
25. Tests and estimates of allelic association in complex inheritance
26. Genetic polymorphisms and disease
27. Monogenic diabetes mellitus in youth. The MODY syndromes
28. Emerging epidemic of type 2 diabetes in youth
29. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
30. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q
31. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)
32. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus
33. Non-sense mutation of glucokinase gene
34. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q
35. Mutations in the hepatocyte nuclear factor-1 alpha gene in maturity-onset diabetes of the young (MODY3)
36. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
37. Molecular and physiologic basis for maturity onset diabetes of youth
38. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)
39. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families
40. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians
41. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes
42. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican-Americans
43. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican-Americans
44. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians
45. Genomewide search for type 2 diabetes susceptibility genes in four American populations
46. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I: An autosomal genome scan for genes that predispose to type 2 diabetes
47. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24
48. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
49. Guilt by association
50. Calpain 10: The first positional cloning of a gene for type 2 diabetes?
51. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23
52. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain
53. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy
54. Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q
55. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene
56. New susceptibility locus for NIDDM is localized to human chromosome 20q
57. Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs
58. Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus
59. Restriction-fragment-length polymorphism in insulin-receptor gene and insulin resistance in NIDDM
60. Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus
61. Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM)
62. A genetic marker at the glucokinase gene locus for type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles
63. Glucokinase gene is genetic marker for NIDDM in American blacks
64. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus
65. Positive association in the absence of linkage suggests a minor role for the glucokinase gene in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus amongst south Indians
66. Polymorphic microsatellite repeat markers at the glucokinase gene locus are positively associated with NIDDM in Japanese
67. Glucokinase gene polymorphisms: A genetic marker for glucose intolerance in a cohort of elderly Finnish men
68. Early-onset type 2 (non-insulin-dependent) diabetes mellitus is associated with glucokinase locus, but not with adenosine deaminase locus, in the Japanese population
69. Trinucleotide repeats at the rad locus: Allele distributions in NIDDM and mapping to a 3-cM region on chromosome 16q
70. Increased and decreased relative risk for non-insulin-dependent diabetes mellitus conferred by HLA class II and by CD4 alleles
71. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: Association or founder effect?
72. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus
73. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: A population association study and molecular scanning in Japanese subjects
74. The population association of glucokinase gene with type 2 (non-insulin-dependent) diabetes mellitus in Chinese
75. Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects
76. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians
77. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations
78. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of non-insulin-dependent diabetes mellitus
79. Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: A population-based study
80. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians
81. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): A meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians
82. An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene
83. A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes
84. C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes letter
85. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
86. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus
87. Variants in the sulphonylurea receptor gene: Association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians
88. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes
89. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan
90. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles
91. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation
92. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes
93. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus
94. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes
95. Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus
96. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects
97. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II: An autosomal genome scan for diabetesrelated quantitative-trait loci
98. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree